{"id":"NCT02106390","sponsor":"GlaxoSmithKline","briefTitle":"Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants","officialTitle":"A Phase 3b, Open-Label, Randomized, Multicenter Study to Assess the Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-06-05","primaryCompletion":"2016-10-14","completion":"2016-10-14","firstPosted":"2014-04-08","resultsPosted":"2018-08-22","lastUpdate":"2018-08-22"},"enrollment":750,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Meningococcal"],"interventions":[{"type":"BIOLOGICAL","name":"Meningococcal group B Vaccine, rMenB+OMV NZ","otherNames":["Bexsero®"]},{"type":"BIOLOGICAL","name":"Meningococcal ACWY Conjugate Vaccine, MenACWY","otherNames":["Menveo®"]}],"arms":[{"label":"rMenB+ACWY","type":"EXPERIMENTAL"},{"label":"rMENB","type":"ACTIVE_COMPARATOR"},{"label":"MenACWY","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this trial is to evaluate the immunogenicity, the safety and the tolerability of rMenB+OMV NZ and MenACWY vaccines in healthy infants, when concomitantly administered at 3, 5, 7 and 13 months of age, compared to either alone.","primaryOutcome":{"measure":"Human Serum Bactericidal Activity (hSBA) Geometric Mean Titers (GMTs) Against Each of the Serogroup B Indicator Strains","timeFrame":"At Day 331 (one month after the fourth vaccination)","effectByArm":[{"arm":"rMenB+ACWY Group","deltaMin":92,"sd":null},{"arm":"rMenB Group","deltaMin":104,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"85 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":7,"countries":["Argentina","Mexico"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":249},"commonTop":["Injection site pain","Crying","Irritability","Injection site erythema","Injection site induration"]}}